In Brazil, this entire complex process, from the collection of tissue samples to the final analysis performed by pathologists, faces important challenges related to organizational, economic, and communication gaps that negatively impact the accurate determination of the HER2 tumor status18. The gene discussed is ERBB2; the disease is neoplasm.